Showing results (771-780 of 1,011) with videos related to
Sort By:
Pageof 102
Cerebrovascular Diseases Extra|September 8, 2016
Early Blood Pressure Lowering Does Not Reduce Growth of Intraventricular Hemorrhage following Acute Intracerebral Hemorrhage: Results of the INTERACT StudiesEdward Chan, Craig S Anderson, Xia Wang, et al.International Journal of Stroke : Official Journal of the International Stroke Society|June 6, 2015
Poor utility of grading scales in acute intracerebral hemorrhage: results from the INTERACT2 trialEmma Heeley, Craig S Anderson, Mark Woodward, et al.Cerebrovascular Diseases (Basel, Switzerland)|August 6, 2025
Influence of multiple long-term conditions on outcome after thrombolysis for acute ischemic stroke: secondary analysis of the ENCHANTED trialXinwen Ren, Yang Zhao, Menglu Ouyang, et al.Stroke|January 11, 2021
Associations of an Abnormal Physiological Score With Outcomes in Acute Intracerebral Hemorrhage: INTERACT2 StudyLili Song, Xia Wang, Menglu Ouyang, et al.Journal of Diabetes|July 2, 2020
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trialHyunju Kim, Dan Wang, John Chalmers, et al.JMIR Research Protocols|August 21, 2025
Development of the Double-Blind, Randomized Trials of Effects of Antihypertensive Medicines (DREAM) Database and Characteristics of the Included Trials: Protocol for an Umbrella Review and Meta-AnalysesAbdul Salam, Rupasvi Dhurjati, Kota Vidyasagar, et al.JAMA|May 28, 2026
Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations: A Network Meta-AnalysisNelson Wang, Stephen Van Der Hoorn, Rashmi Pant, et al.BMJ Open|June 27, 2025
Process evaluation of a randomised trial of a triple low-dose combination pill strategy to improve hypertension control: a qualitative studyAbdul Salam, Tracey Laba, Rupasvi Dhurjati, et al.The Medical Journal of Australia|December 16, 2014
An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trialTracey-Lea Laba, Alison Hayes, Serigne Lo, et al.International Journal of Cardiology|June 23, 2020
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS programClare Arnott, Brendon L Neuen, Hiddo J L Heerspink, et al.Pageof 102